Autonomix Medical, Inc. (AMIX) Earnings History
Net Loss5 years of earnings data (2022–2026) · Currently unprofitable on a TTM basis
Loading earnings history...
Autonomix Medical, Inc. (AMIX) Earnings Overview
As of June 29, 2026, Autonomix Medical, Inc. (AMIX) reported trailing twelve-month net income of -$17M, reflecting +64.1% year-over-year growth. The company earned $-30.77 per diluted share over the past four quarters.
Looking at the long-term picture, AMIX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$2M in fiscal 2023.
Autonomix Medical, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), BSX ($3.55B net income, 14.4% margin), MDT ($4.80B net income, 13.2% margin), AMIX has comparable earnings metrics. Compare AMIX vs NVCR →
AMIX Earnings vs Peers
Earnings metrics vs comparable public companies
AMIX Historical Earnings Data (2022–2026)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | -$17M | -46.5% | -$17M | $-48.72 | - | - |
| 2025 | -$11M | +26.0% | -$12M | $-135.66 | - | - |
| 2024 | -$15M | -675.2% | -$12M | $-442.89 | - | - |
| 2023 | -$2M | +85.1% | -$2M | $-2.31 | - | - |
| 2022 | -$13M | - | -$14M | $-14.91 | - | - |
Download Data
Export AMIX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
4+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AMIX — Frequently Asked Questions
Quick answers to the most common questions about buying AMIX stock.
What is AMIX earnings per share (EPS)?
AMIX trailing twelve-month (TTM) diluted EPS is $-30.77, reflecting +64.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2022 to 2026 is available in the table on this page.
What is Autonomix Medical, Inc.'s net income?
Autonomix Medical, Inc. (AMIX) trailing twelve-month net income is $-17M as of 2026. Earnings grew +64.1% year-over-year.
Is AMIX profitable?
AMIX is not currently profitable on a TTM basis, reporting a net loss of $-17M. Net margin is N/A. Investors should monitor for a return to profitability.
What is AMIX's earnings growth rate?
AMIX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2022 to 2026.
What are AMIX's profit margins?
Autonomix Medical, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -238.9%.
Is AMIX growing earnings?
Yes, AMIX earnings are accelerating — EPS growth of +64.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-17M. Earnings momentum is strengthening.
What was AMIX's best earnings year?
Autonomix Medical, Inc.'s highest annual net income on record is $-2M, achieved in fiscal year 2023. Earnings history on this page spans 2022 to 2026 and includes all annual and quarterly figures.
What were AMIX's earnings last quarter?
AMIX's most recent reported quarter was Q4 2026. Net income was $-3M with diluted EPS of $-4.83. For a full breakdown of all quarters, see the quarterly earnings table on this page.